| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $22.6M | -10.0% |
| Cost of Revenue | $12.7M | -14.7% |
| Gross Profit | $9.9M | -3.2% |
| R&D Expense | $962K | +14.5% |
| SG&A Expense | $11.4M | -4.4% |
| Operating Income | -$4.5M | -2.7% |
| Pre-tax Income | -$4.7M | -3.6% |
| Income Tax | $23K | -30.5% |
| Net Income | -$4.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.4M | +300.0% |
| Accounts Receivable | $6.0M | -10.5% |
| Inventory | $9.6M | -8.7% |
| Current Assets | $22.1M | +9.1% |
| Total Assets | $31.1M | +11.9% |
| Current Liabilities | $16.8M | +60.4% |
| Total Liabilities | $21.0M | +59.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.1M | +593.2% |
| Capital Expenditures | $969K | +1968.6% |
| Investing Cash Flow | -$1.0M | -314.4% |
| Financing Cash Flow | $1.0M | +99.4% |
| Free Cash Flow | $3.1M | +455.3% |
| -3.5% |
| EPS (Basic) | -$0.19 | +0.0% |
| EPS (Diluted) | -$0.19 | +0.0% |
| Stockholders' Equity |
| $10.2M |
| -30.6% |